Coronary interventions

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention

EuroIntervention 2016;11:e1275-e1282 published online e-edition February 2016. DOI: 10.4244/EIJV11I11A249

K. Anette Fiedler
K. Anette Fiedler1*, MD; Gjin Ndrepepa1, MD; Stefanie Schulz1, MD; Simone Floh1; Petra Hoppmann2, MD; Sebastian Kufner1, MD; Isabell Bernlochner2, MD; Robert A. Byrne1, MB, BCh, PhD; Heribert Schunkert1,3, MD; Karl-Ludwig Laugwitz2,3, MD; Adnan Kastrati1,3, MD
1. Deutsches Herzzentrum, Technische Universität, Munich, Germany; 2. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany; 3. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich,

Aims: We aimed to assess the association of bivalirudin with post-procedural Thrombolysis In Myocardial Infarction (TIMI) flow, acute (≤24 hours) and 30-day stent thrombosis (ST), and one

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bivalirudinmortalitypercutaneous coronary interventionstent thrombosistimi flow
Coronary interventionsSTEMIAdjunctive pharmacotherapy
Read next article
Patency of coronary side branches covered by an everolimus-eluting bioresorbable vascular scaffold: clinical outcomes and computed tomography scan follow-up

Latest news